Company News for Dec 9, 2020

Zacks Equity Research Published on December 09, 2020

Shares of Stitch Fix, Inc. (SFIX - Free Report) surged 39.2% after the company reported first-quarter fiscal 2021 earnings of $0.09 per share, beating the Zacks Consensus Estimate of a loss of $0.17.
H&R Block, Inc.’s (HRB - Free Report) shares declined 7.9% after the company reported second-quarter fiscal 2021 adjusted loss of $1.09 per, wider than the Zacks Consensus Estimate of a loss of $0.93.
Shares of Cantel Medical Corp. jumped 21.9% after the company reported first-quarter fiscal 2021 earnings of $0.90 per share, surpassing the Zacks Consensus Estimate of $0.36.
Moderna, Inc.’s (MRNA - Free Report) shares increased 6.5% after Switzerland increased its confirmation orders for its COVID-19 vaccine from 4.5 million.

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.